Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026

Summary

The bill renews existing authority aimed at accelerating the availability of important treatments for amyotrophic lateral sclerosis (ALS). It is intended to help people living with ALS and the medical professionals who treat them by keeping support for rapid therapy access in place. The legislation reflects ongoing concern about timely treatment for this progressive disease.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share